Mei‐Chih Chen
Impact in
-
- Cancer-related Molecular Pathways
- CAR-T cell therapy research
-
- Advanced Glycation End Products research
Papers in
-
- Metabolism, Diabetes, and Cancer 3
- Cell death mechanisms and regulation 3
- Retinoids in leukemia and cellular processes 2
- Oncology 10
- Cancer-related Molecular Pathways 6
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Ho Lin (14 shared papers)Guang‐Yuh Hwang (1 shared paper)Ya-Hui Chou (1 shared paper)Sui‐Chu Yin (1 shared paper)Chieh‐Lin Jerry Teng (4 shared papers)Tsung‐Ying Yang (2 shared papers)Der‐Yang Cho (6 shared papers)Chun‐Chi Wu (1 shared paper)
- Journals
- Journal of Cellular Biochemistry (3 papers)Advanced Science (2 papers)Cell Death and Disease (2 papers)Journal of Nanobiotechnology (2 papers)Anticancer Research (2 papers)
- Partner nations
- TaiwanUnited StatesVietnam
In The Last Decade
Mei‐Chih Chen
36 papers receiving 438 citations
Peers
Comparison fields: 5 of 102
- Oncology 124
- Clinical Biochemistry 30
- Water Science and Technology 51
- Industrial and Manufacturing Engineering 28
- Immunology 64
Countries citing papers authored by Mei‐Chih Chen
This map shows the geographic impact of Mei‐Chih Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei‐Chih Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei‐Chih Chen more than expected).
Fields of papers citing papers by Mei‐Chih Chen
This network shows the impact of papers produced by Mei‐Chih Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei‐Chih Chen. The network helps show where Mei‐Chih Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Mei‐Chih Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 77 | |
| 2 | 1999 | 54 | |
| 3 | 2020 | 53 | |
| 4 | 2023 | 39 | |
| 5 | 2019 | 29 | |
| 6 | 2021 | 16 | |
| 7 | 2024 | 14 | |
| 8 | 2025 | 13 | |
| 9 | 2024 | 12 | |
| 10 | 2019 | 10 | |
| 11 | 2024 | 9 | |
| 12 | 2023 | 9 | |
| 13 | 2015 | 9 | |
| 14 | 2014 | 9 | |
| 15 | 2007 | 9 | |
| 16 | 2022 | 8 | |
| 17 | 2021 | 8 | |
| 18 | 2024 | 8 | |
| 19 | 2024 | 7 | |
| 20 | 2023 | 7 |
About Mei‐Chih Chen
Mei‐Chih Chen is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 36 papers that have together received 444 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), Metabolism, Diabetes, and Cancer (3 papers), Cell death mechanisms and regulation (3 papers), Retinoids in leukemia and cellular processes (2 papers), Fungal Biology and Applications (2 papers), Cancer, Lipids, and Metabolism (2 papers), Advanced Glycation End Products research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Oncology (124 citations), Clinical Biochemistry (30 citations), Water Science and Technology (51 citations), Industrial and Manufacturing Engineering (28 citations) and Immunology (64 citations). Mei‐Chih Chen has collaborated with scholars based in Taiwan, United States and Vietnam. Frequent co-authors include Ho Lin, Guang‐Yuh Hwang, Ya-Hui Chou, Sui‐Chu Yin, Chieh‐Lin Jerry Teng, Tsung‐Ying Yang, Der‐Yang Cho, Chun‐Chi Wu, Gee‐Chen Chang and Shih‐Lan Hsu. Their work appears in journals such as Journal of Cellular Biochemistry, Advanced Science, Cell Death and Disease, Journal of Nanobiotechnology and Anticancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.